Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Zealand Pharma
Related studies linked through entity extraction aliases.
Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
- Status
- COMPLETED
- Phase
- PHASE3
The Bihormonal iLet Bionic Pancreas Feasibility Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)
- Status
- COMPLETED
- Phase
- PHASE3
Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
- Status
- COMPLETED
- Phase
- PHASE3
Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
- Status
- COMPLETED
- Phase
- PHASE3
GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake
- Status
- COMPLETED
- Phase
- NA
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility Trial Testing the Bionic Pancreas With ZP4207
- Status
- COMPLETED
- Phase
- PHASE2
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial Testing ZP1848 in Patients With SBS
- Status
- COMPLETED
- Phase
- PHASE2
Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
- Status
- COMPLETED
- Phase
- PHASE2